珂谧主理人袁妍红：2026年品牌预计营收4亿至5亿元

This article shares key development information about Combe, an emerging beauty brand owned by Focused Health, helping general readers understand the current landscape of popular performance-focused cosmetics and find credible product information.\n1. Core brand information: Founded in 2023 under Focused Health, Combe positions itself in the medical aesthetics space with recombinant collagen as its core ingredient. It focuses on perioperative use cases and anti-aging benefits, and has seen explosive growth. It generated 155 million yuan in revenue in 2025, and hit 169 million yuan in revenue in the first half of 2026, putting it on track to hit 400 to 500 million yuan in full-year 2026, representing year-on-year growth of 158.06% to 222.58%.\n2. Key product insights: Combe's blockbuster product, its transdermal ampoule serum, contributes 85% of total sales. It has sold more than 50 million units cumulatively, generating over 300 million yuan in sales. Independent human testing conducted by SGS confirmed the product delivers visible immediate firming and anti-aging effects in 10 minutes, with results continuing to improve over 28 days. Combe also holds China's first project-level wrinkle reduction product certification, giving its efficacy strong third-party validation.

This article shares the high-growth experience of emerging performance beauty brand Combe and outlines current consumer trends in the cosmetics industry, offering valuable insights for brands mapping out their category strategy.\n1. Product R&D direction: Consumers are increasingly demanding cosmetics with clear, targeted efficacy and segmented positioning. Brands can learn from Combe's playbook: focus on the core ingredient recombinant collagen, target the niche perioperative medical aesthetics segment, concentrate resources on building a flagship core product to drive overall brand growth, and build user trust and strengthen competitiveness through third-party efficacy testing and certification.\n2. Marketing and channel innovation: Combe has pioneered a model of livestream selling in partnership with state media, generating over 100 million yuan in cumulative GMV, with a single-stream high of 19.3 million yuan. Leveraging the authoritative trust of state-owned media effectively solves the trust gap that plagues new brands, making this a model worth adopting.\n3. Industry trend: China's performance cosmetics category as a whole continues to grow rapidly. Focused Health's cosmetics division posted 17.57% year-on-year revenue growth in the first half of 2026, indicating the category still holds considerable room for expansion.

This article discloses the latest growth data for the medical aesthetics performance cosmetics category and summarizes replicable go-to-market strategies, offering valuable insights for beauty sellers looking to identify market opportunities.\n1. Category opportunity: The medical aesthetics performance cosmetics space is still in a high-growth, high-opportunity period, where even new brands can achieve explosive growth. Combe, founded just three years ago, is on track to hit 400 to 500 million yuan in annual revenue, with growth far outpacing the industry average. The 17.57% overall revenue growth of its parent group's cosmetics division further confirms the category's growth potential.\n2. Actionable takeaways: Sellers can adopt Combe's flagship product strategy: concentrate resources on building one core product with well-defined efficacy and authoritative certification to unlock market traction. On the marketing side, partnering with authoritative media for livestream selling is a tested approach that leverages third-party trust to rapidly boost conversion and deliver strong GMV results.\n3. Risk warning: The revenue decline of Focused Health's brand Dr. Alva demonstrates how intense competition in this category is. Brands without clear differentiated positioning risk being squeezed out of the market, so sellers must prioritize avoiding homogenization.

This article outlines current product demand trends in the cosmetics market, providing guidance on strategic positioning and business opportunities for cosmetics manufacturers.\n1. Product design and development demand: Market demand is strong for medical aesthetics-aligned performance cosmetics with clear efficacy. In particular, products centered on recombinant collagen, focused on anti-aging and sensitivity repair, formulated for the perioperative medical aesthetics scenario, and packaged in single-use ampoule formats are more likely to become blockbusters. Manufacturers can proactively build out relevant R&D and production capacity to match this market demand.\n2. Business opportunities: Emerging performance brands are growing rapidly and have strong demand for market expansion, creating high demand for stable, quality-aligned supply chains. Manufacturers that can support brands in completing authoritative efficacy testing and deliver consistent production capacity are far more likely to secure long-term cooperation contracts.\n3. Implications for digital e-commerce: New brands focus heavily on livestream e-commerce, which often generates large order volumes during promotion periods. Manufacturers need to improve production flexibility and build more agile delivery systems to match the online sales rhythm of brand clients.

This article sorts out current development trends in the cosmetics industry and identifies the core pain points of brand owners, offering guidance on business direction for a wide range of beauty industry service providers.\n1. Industry development trend: Performance-focused medical aesthetics cosmetics is the fastest-growing segment of the industry, and new brands still have substantial room for explosive growth. The overall cosmetics industry is recording double-digit growth, driving continued rising demand for supporting industry services.\n2. Core client pain points: The biggest challenge for emerging performance brands is building customer trust. They need authoritative certification to validate product efficacy, as well as reliable channels to drive cold-start growth and quickly capture market share.\n3. Business opportunities: Marketing service providers can develop integrated livestream selling solutions that leverage authoritative media resources, offering brands trust-backed marketing services. Testing and certification providers can expand their product efficacy certification business to meet brands' demand for authoritative validation and capture new market share.

This article discloses beauty brands' channel demands and the key characteristics of high-potential brands, providing guidance for platforms on merchant recruitment and operations.\n1. Brand channel demand: Emerging performance brands place high value on trustable traffic. Beyond conventional influencer livestreaming and in-brand livestreaming, they have strong demand for livestream selling partnerships with authoritative media, a format that delivers strong conversion and helps new brands achieve a successful cold start.\n2. Recruitment priorities: The medical aesthetics performance cosmetics category has spawned many high-growth new brands. Emerging brands like Combe, with clear positioning and a flagship blockbuster product, are on track to hit 400 to 500 million yuan in annual revenue just three years after founding, making them high-quality, high-potential targets for platform recruitment. Platforms should prioritize sourcing brands of this type.\n3. Operations and risk mitigation: Platforms can launch tailored support policies to meet brands' demand for trust-focused marketing. At the same time, they should note that the category is already extremely competitive and prone to homogenization, so platforms should guide brands to pursue clear differentiated positioning to mitigate the risks of widespread homogenized competition.

This article discloses the latest development data and new brand growth models for China's cosmetics industry, offering valuable source material for industrial research.\n1. New industry dynamics: China's cosmetics industry is shifting toward performance-focused, segment-specific positioning. Recombinant collagen and the perioperative medical aesthetics segment have emerged as new growth hotspots, and the 17.57% year-on-year growth of leading group Focused Health's cosmetics division confirms the category's strong growth trajectory. At the same time, uneven growth across the group's portfolio—including the revenue decline of Dr. Alva—demonstrates that competition is already extremely intense, and the Matthew effect is beginning to take hold.\n2. New brand growth model: New brands普遍采用大单品起盘模式，聚焦核心成分与细分场景，集中资源打造一款爆品撬动市场. On the marketing side, they have pioneered the model of livestream selling with state media, leveraging authoritative endorsement to quickly resolve trust issues and achieve cold-start growth. This new model warrants in-depth research.\n3. New research questions: The value of authoritative media livestreaming in enabling beauty brand growth, and the applicability of the flagship product model for new beauty brands, are both new directions that merit further academic and industry research.